Trefzer, U., Gutzmer, R., Wilhelm, T., Schenck, F., Kähler, K.C., Jacobi, V., Witthohn, K., Lentzen, H. und Mohr, P. (2014) „Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure : a phase II, multi-centre study“, Journal for Immuno Therapy of Cancer, (Band 2, Heft 27 (2014), S. , Heft 27 (2014). doi:10.1186/s40425-014-0027-z.
Chicago Manual of Style 17th edition (full note)Trefzer, Uwe, Ralf Gutzmer, Tabea Wilhelm, Florian Schenck, Katharina C. Kähler, Volkmar Jacobi, Klaus Witthohn, Hans Lentzen, und Peter Mohr. „Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure : a phase II, multi-centre study“. Electronic. Journal for Immuno Therapy of Cancer, Nr. Band 2, Heft 27 (2014) ([2014?]): , Heft 27 (2014). https://doi.org/10.1186/s40425-014-0027-z.
American Psychological Association 7th editionTrefzer, U., Gutzmer, R., Wilhelm, T., Schenck, F., Kähler, K. C., Jacobi, V., Witthohn, K., Lentzen, H., & Mohr, P. (ca. 2014). Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure : a phase II, multi-centre study [Electronic]. Journal for Immuno Therapy of Cancer, Band 2, Heft 27 (2014), , Heft 27 (2014). https://doi.org/10.1186/s40425-014-0027-z
Modern Language Association 9th editionTrefzer, U., R. Gutzmer, T. Wilhelm, F. Schenck, K. C. Kähler, V. Jacobi, K. Witthohn, H. Lentzen, und P. Mohr. „Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure : a phase II, multi-centre study“. Journal for Immuno Therapy of Cancer, electronic, Nr. Band 2, Heft 27 (2014), London : Bio Med Central, 2013-, 2014, S. , Heft 27 (2014), https://doi.org/10.1186/s40425-014-0027-z.
ISO-690 (author-date, Deutsch)TREFZER, Uwe, Ralf GUTZMER, Tabea WILHELM, Florian SCHENCK, Katharina C. KÄHLER, Volkmar JACOBI, Klaus WITTHOHN, Hans LENTZEN und Peter MOHR, 2014. Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure : a phase II, multi-centre study. Journal for Immuno Therapy of Cancer. 2014. Nr. Band 2, Heft 27 (2014), S. , Heft 27 (2014). DOI 10.1186/s40425-014-0027-z